The FDA has denied Lykos Therapeutics' marketing application for its post-traumatic stress disorder (PTSD) therapy based on MDMA, also known as ecstasy, in a setback for the emerging psychedelic ...

Multidisciplinary Association for Psychedelic Studies (MAPS), the FDA has agreed study designs for two phase 3 studies assessing MDMA-assisted psychotherapy for patients with severe PTSD.

The Defense Department is committing two $4.9 million grants to study the effects of MDMA on post-traumatic stress disorder, one of which will enroll active-duty troops as subjects. Pictured is ...

Emory is poised to expand its research on how MDMA, a psychedelic drug commonly known as ecstasy, could help patients with PTSD when coupled with psychotherapy.

Australia’s first clinical practice guideline on the appropriate use of methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP) to treat post-traumatic stress disorder (PTSD) is a step closer ...